Namur Thrombosis and Hemostasis Center

INIS

1. accuracy 7%
2. adhesion 6%
3. administration 18%
4. antibodies 20%
5. anticoagulants 76%
6. applications 18%
7. assessments 33%
8. biological markers 15%
9. blood 18%
10. blood coagulation 6%
11. cancer 14%
12. capacity 6%
13. clinical trials 7%
14. comparative evaluations 38%
15. concentration 37%
16. control 20%
17. coronaviruses 10%
18. covid-19 16%
19. data 30%
20. design 10%
21. detection 11%
22. dimers 6%
23. diseases 23%
24. doses 21%
25. drugs 34%
26. economics 6%
27. emergencies 11%
28. endothelium 7%
29. estrogens 12%
30. evaluation 29%
31. fibrinolysis 6%
32. hemolysis 5%
33. hemostatics 10%
34. heparin 26%
35. hormones 6%
36. humans 14%
37. in vitro 17%
38. in vivo 12%
39. inflammation 12%
40. information 14%
41. inhibition 19%
42. interactions 9%
43. investigations 5%
44. kidneys 6%
45. kinases 17%
46. laboratories 41%
47. levels 25%
48. ligands 5%
49. liver 6%
50. lungs 6%
51. management 9%
52. mass spectrometry 9%
53. medicines 6%
54. metabolism 5%
55. molecular weight 12%
56. molecules 7%
57. monitoring 18%
58. mortality 5%
59. myeloid leukemia 11%
60. nanoparticles 17%
61. neutrophils 10%
62. patients 100%
63. peaks 6%
64. performance 19%
65. plasma 48%
66. populations 6%
67. production 10%
68. proteins 35%
69. prothrombin 7%
70. range 10%
71. rats 14%
72. reagents 15%
73. receptors 14%
74. recommendations 9%
75. reduction 6%
76. reviews 44%
77. risks 49%
78. safety 17%
79. screening 18%
80. sensitivity 19%
81. standardization 10%
82. substrates 5%
83. surgery 9%
84. symptoms 5%
85. synthesis 12%
86. testing 28%
87. therapy 11%
88. thrombin 52%
89. thromboplastin 8%
90. thrombosis 19%
91. tissues 10%
92. toxicity 10%
93. tyrosine 17%
94. vaccines 14%
95. validation 13%
96. values 20%
97. venoms 8%
98. vitamin k 12%
99. wave forms 6%
100. women 14%